Game-changing pan-TEAD inhibitor for solid tumours
Drug Target Review
JUNE 12, 2023
What are the preclinical characteristics of ISM6331, including its efficacy, safety profile, and drug metabolism and pharmacokinetics (DMPK) properties? The system optimised the molecules that were most likely to succeed in terms of potency, metabolic stability, synthetic accessibility, and more.
92 
Let's personalize your content